Genmab — September 2017
-
Genmabs salg af Darzalex tager fart i august
Salget af Genmabs kræftmiddel Darzalex tog et pænt spring frem på det amerikanske marked i august efter et relativt afdæmpet salg i juli.
(medwatch.dk)
-
Mon ikke vi lige skal have septemeber og oktober med.
-
Ja alt andet lige må det begynde at tage fart - duration (responsrate), 3 linie USA, 2 linie europa, 1 linie off label, nye lande kommer til, godkendelse Japan. Salget kan pt boostes fra mange sider af, så hvis de bare hver især bidrager lidt, så ligner det stadig en opjustering sidst på året
-
Min korte kommentart på Play: https://play.borsen.dk/social/59c1576445628ff81720d7ac
-
Og du brugte ordet "salgstal"

-
-
LOL

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind